Impact of the COVID-19 pandemic on clinical trials with drugs

Expert Opin Drug Saf. 2020 Nov;19(11):1373-1375. doi: 10.1080/14740338.2020.1828861. Epub 2020 Oct 8.

Author

Joerg Hasford^{1

2}

Affiliations

¹ Institute for Medical Informatics, Biometry and Epidemiology, Ludwigs-Maximilians-Universitaet Muenchen , Muenchen, Germany.
² Association of Medical Ethics Committees in Germany , Berlin, Germany.

PMID: 32970481
DOI: 10.1080/14740338.2020.1828861

No abstract available

Keywords: clinical trials; clinical trials regulation; covid-19; pandemic; patient involvement.

Publication types

Editorial

MeSH terms

COVID-19
Clinical Trials as Topic / organization & administration*
Coronavirus Infections* / diagnosis
Coronavirus Infections* / epidemiology
Coronavirus Infections* / therapy
Coronavirus Infections* / transmission
Delivery of Health Care, Integrated / organization & administration*
Humans
Infection Control / organization & administration*
Infectious Disease Transmission, Patient-to-Professional / prevention & control
Infectious Disease Transmission, Professional-to-Patient / prevention & control
Occupational Health
Pandemics*
Patient Safety
Pneumonia, Viral* / diagnosis
Pneumonia, Viral* / epidemiology
Pneumonia, Viral* / therapy
Pneumonia, Viral* / transmission
Psychological Distance
Research Design*
Research Personnel / organization & administration*
Risk Factors